Suntrust Banks’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.73M Buy
90,331
+20,750
+30% +$487K 0.01% 624
2019
Q2
$1.53M Buy
69,581
+30,212
+77% +$663K 0.01% 671
2019
Q1
$805K Sell
39,369
-590
-1% -$10.3K ﹤0.01% 823
2018
Q4
$504K Buy
39,959
+1,028
+3% +$15.3K ﹤0.01% 888
2018
Q3
$597K Sell
38,931
-176
-0.5% -$2.43K ﹤0.01% 860
2018
Q2
$512K Buy
39,107
+17,158
+78% +$189K ﹤0.01% 912
2018
Q1
$179K Sell
21,949
-187
-0.8% -$1.51K ﹤0.01% 1222
2017
Q4
$196K Sell
22,136
-5,442
-20% -$50.2K ﹤0.01% 1177
2017
Q3
$307K Sell
27,578
-991
-3% -$9.64K ﹤0.01% 1043
2017
Q2
$256K Buy
28,569
+5,330
+23% +$42.3K ﹤0.01% 1118
2017
Q1
$183K Sell
23,239
-8,194
-26% -$66.7K ﹤0.01% 1201
2016
Q4
$268K Buy
+31,433
New +$269K ﹤0.01% 1320
2016
Q3
Sell
-14,287
Closed -$114K 1569
2016
Q2
$114K Buy
+14,287
New +$115K ﹤0.01% 1458

Other funds holding NEO

Suntrust Banks's NEO Position: Q3 2019 in Review

Suntrust Banks increased its NeoGenomics (NEO) stake by 30% in Q3 2019, buying an estimated $487K and bringing the position to 90,331 shares worth $1.73M. The position accounts for 0.01% of the portfolio, ranked #624.

Suntrust Banks first reported a position in NEO in Q2 2016 and has held it in 13 quarters since. 253 funds tracked by Wall St. Rank hold NEO as of Q3 2019.

  • Suntrust Banks held 90,331 shares of NeoGenomics worth $1.73M as of Q3 2019.
  • Suntrust Banks bought 20,750 NeoGenomics shares in Q3 2019, an estimated $487K.
  • NeoGenomics made up 0.01% of Suntrust Banks's portfolio in Q3 2019, its #624 holding.
  • Suntrust Banks first reported a position in NeoGenomics in Q2 2016 and has held it in 13 quarters since.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.